Reframe Cancer appoints non-executive director from health insurance industry

Reframe Cancer, which works with a number of insurers, has appointed Jenni Wilson as a non-executive director as it looks to further grow the business.

Wilson has over 30 years’ commercial expertise in health insurance, hospitals and healthcare, having held director roles at Bupa, Axa, Nuffield Health and Simplyhealth, Denplan.  

Reframe Cancer provides cancer navigation and support to a wide range of insurers including Unum, Lime Health, Pulse Insurance and employers such as  Meta and Salesforce. It has experienced a period of rapid growth in 2024 with a number of new direct partnerships.

Reframe Cancer CEO Mark Stephenson says this appointment will help ensure the company continues to serve the evolving needs of insurers, brokers, and providers. He adds: “With [Wilson] on board, we’re now better equipped to deliver tailored solutions that meet the unique requirements of each segment.”

Wilson says: “The need for high quality support products for insurers, providers, employees and patients impacted by cancer has never been more important, especially with cancer rates rising amongst younger people. 

“Reframe Cancer are trusted cancer experts who complement and enhance clinical plans, helping people to navigate their individual cancer journeys.” She said she hoped her experience and expertise would enable the company to continue to deliver new products and continue to grow as a business. 

Exit mobile version